
ESLA vs GRML
$ESLA vs $GRML head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
ESLA vs GRML: the quick read
- ·GRML is the larger company by market cap ($49M vs $22M).
- ·GRML has been more active on our scanner (113 vs 97 alerts in 30 days).
- ·GRML has the smaller float (13.7M vs 43.5M), which tends to mean sharper, more volatile moves.
- ·These sit in different industries (Biological Products, (No Diagnostic Substances) vs BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)), so they answer to different catalysts and a move in one says little about the other.
- ·ESLA trades at a small fraction of the other's share price, so position sizing and the size of a "normal" move differ a lot between them.
- ·Both stay busy on our scanner, 113 and 97 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·Both sit in the bottom quarter of their 52-week range, so this is a comparison of two names well off their highs.
Objective differences only. Not investment advice.
Watching ESLA or GRML? Get each morning’s movers by email
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing ESLA and GRML on TheDesperateTrader.
- Is ESLA or GRML the better stock?
- "Better" depends on your goal, and these two are not alike. GRML is the larger company by market cap ($49M vs $22M). GRML has been more active on our scanner (113 vs 97 alerts in 30 days). GRML has the smaller float (13.7M vs 43.5M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between ESLA and GRML?
- The differences that matter: they are not in the same business - ESLA is biological products, (no diagnostic substances) and GRML is biological products, (no diagnostic substances); they are similar in size ($22M vs $49M); they trade at very different share prices ($0.51 vs $3.61); ESLA sits at 12% of its 52-week range against 19% for GRML; our scanner flagged ESLA 97 times in the last 30 days against 113 for GRML. Everything above is measured from the latest completed session and SEC filings.
- Which of ESLA and GRML is more active right now?
- Right now ESLA is at about 0.1x its normal volume and GRML is at about 0.1x, so GRML is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading ESLA or GRML? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore ESLA and GRML comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.